Intuition Robotics: Company Profile
Intuition Robotics' ElliQ wins Washington Medicaid coverage as a Smart Care Device, marking the first statewide reimbursement model for eldercare companion robots and a potential inflection point for institutional adoption.
- ~$81–83M Total funding raised Series A through Series C plus venture debt; CBInsights, Tracxn
- $20M Series C round (Aug 2023) Plus $5M venture debt facility closed same date
- ~95 Employees as of mid-2024 Tracxn
- 5th of 167 Tracxn rank among tracked competitors Service robotics subsegment
- HQ
- Tel Aviv, Israel
- Founded
- 2015 (incorporated January 16, 2016)
- Employees
- ~95 (mid-2024)
- Segments
- Infrastructure
- Products
- ElliQ (AI companion robot)
- Competitors
- iRobot·Physical Intelligence
ElliQ's Medicaid Win Puts Intuition Robotics at a Critical Inflection Point
Intuition Robotics has spent nearly a decade building an AI-powered companion robot for older adults. In March 2026, Washington state's decision to cover its ElliQ device under Medicaid as a "Smart Care Device" delivered something the eldercare robotics sector has never had: a statewide reimbursement model. Whether that milestone translates into institutional-scale deployment — or remains an isolated policy win — will define the company's next chapter.
Business Overview
Founded in 2015 and incorporated in Israel in January 2016, Intuition Robotics operates at the intersection of AI software, consumer robotics hardware, and eldercare services. The company has raised approximately $81–83M in total funding across multiple rounds, including a $20M Series C closed in August 2023 alongside a $5M venture debt facility. A strategic minority investment from Kanematsu, a major Japanese trading and technology conglomerate, followed in September 2025.
Reimbursement pathways are the primary structural barrier to institutional adoption of companion robotics, and establishing a precedent — even in a single state — changes the sales conversation with senior living operators, insurers, and government aging agencies across the country.
The investor roster is strategically dense for a company of this size: Toyota Research Institute (Series A), Sompo Holdings (Series B), Woven Capital and Toyota Ventures (Series C), iRobot, Bloomberg Beta, and OurCrowd. The concentration of Japanese corporate investors — Sompo, Woven Capital, Kanematsu — is deliberate. Japan's demographic profile, with over 29% of its population aged 65 or older, represents the most acute near-term addressable market for eldercare companion technology globally.
Headcount stood at approximately 95 employees as of mid-2024, a lean base for a company managing simultaneous hardware iteration, AI software development, multi-jurisdiction regulatory compliance, and institutional sales.
Technology and Product
ElliQ is a tabletop robot with an integrated screen designed for indoor, aging-in-place use. Its interaction model centers on proactive engagement — the device initiates conversations, wellness check-ins, medication reminders, and entertainment prompts rather than waiting passively for user input. Interaction modes include two-way video communication, voice commands, and conversational AI dialogue.
The product's differentiation lies in its software architecture rather than its hardware form factor. Proactive, context-aware AI engagement is harder to replicate than a screen-and-speaker assembly, and longitudinal interaction data from deployed units could compound into a meaningful training advantage — though deployment scale remains unverified in public sources (LOW CONFIDENCE on data flywheel maturity).
Deployment status is classified as LIMITED. No public figures exist for units shipped, active users, or retention rates beyond the initial novelty period.
Market Position and Competitive Landscape
| Dimension | Intuition Robotics (ElliQ) | Typical Competing Approach |
|---|---|---|
| Form factor | Purpose-built tabletop robot | General tablet / smart speaker |
| Interaction model | Proactive AI-initiated | Reactive / on-demand |
| Target channel | Institutional (payors, operators) | Direct-to-consumer |
| Reimbursement status | Washington Medicaid (2026) | None established |
| Funding raised | ~$81–83M | Varies widely |
| Headcount | ~95 (mid-2024) | — |
Tracxn ranks Intuition Robotics 5th among 167 tracked competitors in its service robotics subsegment — meaningful brand recognition relative to its capital base. The more consequential competitive pressure comes from two directions: well-capitalized frontier robotics platforms that attract disproportionate investor attention, and low-cost tablet or app-based solutions that can undercut hardware companions on price without requiring device logistics or support infrastructure.
The Washington Medicaid coverage designation is the most significant moat-building event in the company's history. Reimbursement pathways are the primary structural barrier to institutional adoption of companion robotics, and establishing a precedent — even in a single state — changes the sales conversation with senior living operators, insurers, and government aging agencies across the country. HIGH CONFIDENCE this is a material commercial catalyst; LOW CONFIDENCE on timeline for replication in other states or federal programs.
Outlook
The bull case rests on three executable catalysts: Kanematsu converting its strategic investment into concrete APAC distribution agreements, the Washington Medicaid model replicating in additional states or influencing Medicare Advantage coverage decisions, and independent outcomes data demonstrating measurable reductions in acute care utilization or loneliness metrics among ElliQ users.
The bear case is straightforward: unit economics for hardware-plus-service models in eldercare are historically punishing, consumer engagement decay beyond the novelty period is a documented risk across companion device categories, and the company's entire commercial trajectory remains opaque. No revenue, no margin data, no customer counts are publicly available.
At 95 employees and roughly $81–83M raised over nine years, Intuition Robotics is running a long game in a market that is structurally growing but institutionally slow. The Washington Medicaid decision is the first concrete evidence that the institutional pathway is open. Execution against it — at scale, with verifiable metrics — is what separates a durable business from a well-funded proof of concept.
Rating: WATCH. Coverage Priority Score: 31/100.